Services
>
Clinical Trial Rescue CRO

Clinical Trial Rescue CRO

Mobius supports medical device, IVD, pharma, biotech, and digital health sponsors with clinical trial rescue, CRO oversight, monitoring remediation, recruitment recovery, data quality review, and structured CRO takeover across Australia, New Zealand, and the United States.

Talk to Mobius about study rescue

When a clinical trial needs rescue

Most struggling trials do not fail all at once. They drift. Sites are activated but not enrolling, monitoring reports arrive late, action items stay open, data queries increase, and the sponsor still cannot see the real operational risk.

Review
Clarify the current study state, separate recoverable issues from structural problems, and identify what needs action first.
Recover
Target the operational issues most likely to protect recruitment, data quality, safety processes, and site performance.
Handover
Plan structured CRO transition or vendor handover where the current delivery model is no longer fit for purpose.

The scenarios sponsors bring to Mobius

Sponsors usually contact Mobius when the CRO says the study is active, but the sponsor cannot tell what is actually blocking progress.
01
Sites open but not enrolling. The site list looks active, but screening is low, referrals are weak, eligibility assumptions were too optimistic, or site teams are not engaged enough.
02
Monitoring is behind or not useful. Visits are delayed, reports are inconsistent, follow-up letters are late, action items are not closed, or the model is not finding what matters.
03
Data quality is deteriorating. Missing data, unresolved queries, protocol deviations, inconsistent source documentation, or late data entry are creating concern.
04
The CRO is not escalating clearly. The sponsor receives updates, but not enough operational judgement. Risks are described too late and proposed fixes are too generic.

Rescue does not always mean replacing the CRO

A trial rescue can take different forms. Sometimes the current CRO remains in place, but the sponsor needs stronger oversight, clearer escalation, independent review, or targeted operational support.

In other cases, the current delivery model is no longer fit for purpose and a structured CRO transition is needed. Mobius can support both paths.

Explore CRO takeover for an underperforming trial

CRO takeover support ->

What Mobius reviews first

A rescue engagement should start with evidence, not opinion. Mobius typically reviews recruitment, site activation, monitoring backlog, open action items, protocol deviations, data quality, safety processes, vendor roles, TMF completeness, and sponsor oversight cadence.

This gives the sponsor a clearer view of where the trial is failing operationally and which actions should happen first.

Explore clinical trial execution

Clinical trial execution ->

Rescue support across product areas

Mobius supports rescue and recovery work across medical device, IVD, pharma, biotech, and digital health studies.

The rescue question is product-aware: medical device studies may involve user training and device accountability, IVD studies may involve sample traceability, and pharma or biotech studies may involve safety review, monitoring intensity, and database timelines.

Explore Mobius services

Mobius services ->

Questions sponsors ask about clinical trial rescue

Short answers for sponsors deciding whether a study needs rescue, stronger oversight, or structured CRO transition.

What is a clinical trial rescue CRO?

A clinical trial rescue CRO helps sponsors recover studies that are not progressing as expected. This may include reviewing recruitment, site activation, monitoring, data quality, vendor performance, safety processes, documentation, and sponsor oversight to create a practical recovery plan.

When should a sponsor consider clinical trial rescue support?

Sponsors should consider rescue support when a study is behind schedule, sites are not enrolling, monitoring is backlogged, data quality is deteriorating, action items are not closing, or the sponsor does not have clear visibility into what is happening across the trial.

Does rescue support mean replacing the current CRO?

Not always. Mobius can support targeted rescue or CRO oversight while the current CRO remains in place. If the existing model is no longer workable, Mobius can also help plan a structured CRO takeover or vendor handover.

Can Mobius take over an underperforming clinical trial?

Mobius can support CRO takeover planning and transition where a study needs to move from an underperforming CRO or vendor model. The first step is usually a structured review of study status, open risks, documents, data, monitoring, site relationships, and handover requirements.

What product areas does Mobius support for rescue studies?

Mobius supports rescue and recovery work across medical device, IVD, pharma, biotech, and digital health studies across Australia, New Zealand, and the United States.

Talk to Mobius ->

Ask Mobius to review a trial that is not on track

Tell us where the study is stuck, what your current CRO or vendor model looks like, and where sponsor confidence is breaking down.

Schedule A Call